NCT05933577 · Interventional trial
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
Overall registry status Active not recruiting
Phase 3
Conditions Melanoma
Delaware Valley sites
- Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 1905) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory